Payamifar Sara, Khalili Yasaman, Foroozandeh Amin, Abdouss Majid, Hasanzadeh Mohammad
Department of Chemistry, Amirkabir University of Technology Tehran Iran
School of Chemistry, Faculty of Science, University of Tehran Iran.
RSC Adv. 2025 May 14;15(20):16050-16074. doi: 10.1039/d5ra00948k. eCollection 2025 May 12.
Magnetic mesoporous silica nanoparticles (MMS NPs) stand out as excellent options for targeted chemotherapy owing to their remarkable features, such as extensive surface area, substantial pore volume, adjustable and uniform pore size, facile scalability, and versatile surface chemistry. This review comprehensively explores the latest developments in MMS NPs, emphasizing their design, functionalization, and application in cancer therapy. Initially, we discuss the critical need for targeted and controlled drug delivery (DD) in oncology, highlighting the role of magnetic and MMs in addressing some challenges. Subsequently, the key features of MMS NPs, such as their high surface area, pore structure, and functionalization strategies, are examined for their impact on their DD performance for efficient cancer chemotherapy. The integration of chemotherapy methods such as photothermal therapy and photodynamic therapy with MMS NPs is also explored, showcasing multifunctional platforms that combine imaging and therapeutic capabilities. Finally, we identify the current challenges and provide future perspectives for the development and clinical translation of MMS NPs, underscoring their potential to reshape CT paradigms.
磁性介孔二氧化硅纳米粒子(MMS NPs)因其卓越的特性,如大表面积、大孔体积、可调节且均匀的孔径、易于规模化生产以及多功能表面化学性质等,成为靶向化疗的理想选择。本综述全面探讨了MMS NPs的最新进展,重点阐述了其设计、功能化以及在癌症治疗中的应用。首先,我们讨论了肿瘤学中靶向和可控药物递送(DD)的迫切需求,强调了磁性和介孔材料在应对一些挑战方面的作用。随后,研究了MMS NPs的关键特性,如高表面积、孔结构和功能化策略,以考察它们对高效癌症化疗的药物递送性能的影响。还探讨了光热疗法和光动力疗法等化疗方法与MMS NPs的结合,展示了兼具成像和治疗能力的多功能平台。最后,我们确定了当前面临的挑战,并为MMS NPs的开发和临床转化提供了未来展望,强调了它们重塑癌症治疗范式的潜力。
ACS Biomater Sci Eng. 2019-10-14
Adv Healthc Mater. 2025-2-10
J Control Release. 2021-9-10
Nanotheranostics. 2019-1-1
ACS Appl Mater Interfaces. 2017-3-16
Eur J Med Chem. 2024-10-5
Expert Opin Drug Deliv. 2023
Mol Biol Rep. 2023-11